
EXHIBITION
This year’s exhibition will be open 24 hours a day, but there are some important times to note:
Thursday 8 October | Start Time – CET | End Time – CET |
Live Scientific Programme | 09:00 | 18:00 |
Replay Scientific Programme | 21:00 | 06:00 |
Friday 9 October | Start Time – CET | End Time – CET |
Live Scientific Programme | 08:00 | 18:15 |
Replay Scientific Programme | 20:00 | 06:15 |
Saturday 10 October | Start Time – CET | End Time – CET |
Live Scientific Programme | 08:00 | 17:45 |
Replay Scientific Programme | 20:00 | 05:45 |
Exhibition Hall A
ABIOMED
American Association for Thoracic Surgery (AATS)
AngioDynamics
Delacroix-Chevalier
The European Board of Cardiovascular Perfusion (EBCP)
Edwards Lifesciences
Getinge
Latinoamerican Association of Cardiac and Endovascular Surgery (LACES)
Medistim
Oxford University Press
Redax
Terumo Aortic
Terumo Cardiovascular
The Society of Thoracic Surgeons (STS)
Exhibition Hall B
3-D Matrix
Abbott
AtriCure
CTSNet
CytoSorbents Europe GmbH
Ethicon
European Society of Cardiology (ESC)
Eurosets
Heart Valve Society
International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS)
Medtronic
Nordic Pharma
Radcliffe Cardiology
Spectrum Medical
Transonic
SATELLITE SYMPOSIA
The following companies will be organising satellite symposia during the 34th Annual Meeting.
These sponsored programmes do not form part of the official scientific programme of EACTS.
Thursday 8th October, 09:00-10:15
3-D Matrix
Date: Thursday 8 October
Time: 09:00-10:15
Room: 212
The Use of a Novel Self-Assembling Peptide for Haemostasis in Cardiac Surgery
Moderator: Professor Roussel
Introduction to PuraStat
Professor Roussel
Perspectives on PuraStat
Professor Di Bartolomeo
Overview of the Clinical Data
Professor Ohri
Above and Beyond with PuraStat
Dr Astudillo
Summary & Live Q&A
Abbott
Date: Thursday 8 October
Time: 09:00-10:15
Room: 118/119
Surgical aortic valve replacement: how to manage past, present and future.
Michael Borger, Germany
Introduction
Michael Borger, Germany
How long do Tissue Heart Valves really last?
Gebrine El Khoury, Belgium
Valve-in-Valve, what’s the latest evidence?
Danny Dvir, Israel
Mechanical Heart Valves: why and when?
Angel Gonzalez Pinto, Spain
Conclusion
Michael Borger, Germany
Please click HERE for the PDF programme.
Abiomed
Date: Thursday 8 October
Time: 09:00-10:15
Room: 116/117
From bridging to next Tx to native heart recovery – are there new options?
Moderators: Professor Daniel Zimpfer; Professor Bart Meyns
What to do in Patients with severe Myocarditis that still have a chance to recover?
Professor Payam Akyhari
Optimizing patient management of midterm PCMS in patients undergoing complex cardiac surgery anticipating a longer path towards recovery.
Dr Alexander Bernhardt
The surgical perspective on right heart failure.
Professor Christoph Starck
LivaNova
Date: Thursday 8 October
Time: 09:00-10:15
Room: 211
When complex can be simpler – The Perceval Platform
Moderator: Professor Bart Meuris, Leuven, Belgium
Minimized incision – maximized vision: an ideal approach for Perceval
Dr Alaaddin Yilmaz, Hasselt, Belgium
Multimodal Valve Therapy: The 360° Approach with Perceval – optimizing MICS
Dr Manuel Wilbring, Dresden, Germany
Perceval (Plus) in multivalve procedures – When time really matters
Professor Alexander Weymann, Essen, Germany
Please click HERE for the PDF programme
Medtronic
Date: Thursday 8 October
Time: 09:00-10:15
Room: Forum
HEART TEAM DECISIONS IN TIMES OF EVOLVING INDICATIONS
Moderator: Professor T. Modine (Bordeaux, France)
Mini AVR in 2020 and beyond
Professor M. Di Eusanio (Ancona, Italy)
Expanding options for bicuspid aortic stenosis patients – TAVI or SAVR
Professor S. Bleiziffer (Bad Oeynhausen, Germany)
The Right choice for Low Risk aortic stenosis patients – TAVI or SAVR?
Professor T. Modine (Bordeaux, France)
Please click HERE for the PDF programme
Terumo Aortic
Date: Thursday 8 October
Time: 09:00-10:15
Room: 111/112
Past, present and future of aortic repair: from root to the descending thoracic aorta
Moderator: Dr Joseph Bavaria
UK Experience of FET for acute type A dissection – Thoraflex Hybrid vs Conventional Therapy
Dr Geoff Tsang
Mid-term results of orthotopic branched endovascular aortic arch repair: outcomes in 43 patients treated with RelayBranch in Europe and Japan
Professor Martin Czerny
The 20th Year Anniversary – Gelweave Valsalva the gold standard for valve sparing root surgery
Professor Ruggero De Paulis
Friday 9th October, 13:15-14:30
Abbott
Date: Friday 9 October
Time: 13:15-14:30
Room: 111/112
Surrounding advanced Heart Failure
Moderators: Ivan Netuka, Czech Republic; Daniel Zimpfer, Austria
Introduction
Ivan Netuka, Czech Republic; Daniel Zimpfer, Austria
Improving Outcomes of advanced heart failure patients by means of advanced surgical approaches
Daniel Zimpfer, Austria
Bridging patients from ECMO to LVAD: Best practices to ensure best outcomes
Ana Gonzales Román, Spain
COVID-19: The quest to avoid collateral damages to patients in need of advanced HF therapies
Marie-Cecile Bories, France; Ramzi Abi Akar, France
Optimized patient management leading to superior outcomes with latest LVAD technologies
Ivan Netuka, Czech Republic
Closing
Ivan Netuka, Czech Republic; Daniel Zimpfer, Austria
Please click HERE for the PDF programme
Abbott
Date: Friday 9 October
Time: 13:15-14:30
Room: Forum
The New Age of Transcatheter Mitral Valve Implantation
Moderators: Thomas Modine, France; Erwan Donal, France
Introduction
Thomas Modine, France
Integrating transcatheter mitral valve implantation therapy into surgical practice
Hendrik Treede, Germany
Determining anatomic suitability
Lenard Conradi, Germany
Optimizing post-op TMVI patient management
Gry Dahle, Norway
Conclusion
Erwan Donal, France
Please click HERE for the PDF programme
AtriCure
Date: Friday 9 October
Time: 13:15-14:30
Room: 211
Emerging Concepts of Hybrid AF options
Moderator: Professor Piotr Suwalski, Warsaw
Persistent AF, Why go Hybrid?
Professor Jaswinder Gill, London
New Approaches for Thoracoscopic Treatment of AF and the LAA
Dr Bart Maesen, Maastricht
Implementing a convergent procedure programme: Minimally invasive Hybrid procedure for Lone Atrial Fibrillation. The Convergent Procedure
Mr Aziz Momin, London
Importance of the Team Approach for Convergent Hybrid AF Ablations
Dr Riyaz Kaba, London
CytoSorbents
Date: Friday 9 October
Time: 13:15-14:30
Room: 212
Actual data and clinical experiences on CytoSorb hemoadsorption in various cardiac surgery indications*
Moderators: Jan Gummert, Bad Oeynhausen; Christophe Baufreton, Angers
Mitral valve endocarditis – new chances to improve the outcome
Daniel Wendt, Essen
Aortic surgery – modulation of the inflammatory response
Yahtin Mehta, Gurgaon
Removal of Ticagrelor during emergency heart surgery – reduction of complications and costs
Stephan Geidel, Hamburg
The special case: Successful treatment of rhabdomyolysis following heart transplantation
Udo Boeken, Duesseldorf
*Simultaneous translation is available for this symposium
Edwards Lifesciences
Date: Friday 9 October
Time: 13:15-14:30
Room: 116/117
Treatment of aortic stenosis: new learnings for the decade
Moderator: Jose L Pomar
Place of surgical AVR in octogenarians and nonagenarians in 2020: state of the art.
Krzysztof Bartus
Structural valve deterioration. What is the next step after VARC 2 guidelines.
Philippe Pibarot
Prevention of thromboembolic events following AVR: aspirin/anti vitamin K/NOAC. Where are we standing?
Nikolaos Bonaros
INSPIRIS RESILIA aortic valve: a clinical body of evidence.
Martin Andreas
Please click HERE for the PDF programme
Medtronic
Date: Friday 9 October
Time: 13:15-14:30
Room: 118/119
OPTIMAL CARDIAC SURGICAL CARE – ARE WE THERE YET?
Moderators: Professor Michael Borger; Professor Thomas Modine
Clinical performance of the Avalus Pericardial Aortic Valve after four years
Professor Robert Klautz
A standardized epicardial concept for the standalone treatment of longstanding-persistent AF – evolution of a procedure with added value
Dr Niels Verberkmoes
Optimizing tricuspid repair: initial experience with the new Tri-Ad 2.0 annuloplasty band
Professor Omer Dzemali
Panel discussion
Please click HERE for the PDF programme
Medtronic
Date: Friday 9 October
Time: 13:15-14:30
Room: 120
THE HVAD™ SYSTEM: EXPERTS SHARE EXPERIENCES WITH 10 YEARS OF RELIABILITY, VERSATILITY AND SMART TECHNOLOGY
Moderator: Professor Stephan Schueler (Newcastle, UK)
Introduction
Professor Stephan Schueler (Newcastle, UK)
A decade of worldwide clinical experience and data from a single center in using HVAD
Professor Evgenij Potapov (Berlin, Germany)
Enhanced versatility of the HVAD allows the treatment of complex cardiac disease and less traumatic surgical implantation techniques have improved long term outcomes
Professor Daniel Zimpfer (Vienna, Austria)
Unique inbuilt monitoring technology for precise hemodynamic control and novel innovations will take longterm LVAD therapy to a new level – An outlook
Dr Sebastian Schulte Eistrup (Bad Rothenfelde, Germany)
Panel discussion
Dr Khaldoon Alhumood (Kuwait-City, Kuwait); Dr Meindert Palmen, (Leiden, The Netherlands); Thomas Schlöglhofer, MSc. (Vienna, Austria)
Please click HERE for the PDF programme
By attending these satellite sessions please be aware that you will be giving permission for your personal details to be shared with the company holding the symposium.